Understanding SARS-CoV-2: Genetic Diversity, Transmission and Cure in Human

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

(2020) Manli Wang et al.   CELL RESEARCH

Chloroquine for the 2019 novel coronavirus SARS-CoV-2

(2020) Philippe Colson et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

2019 novel coronavirus infection and gastrointestinal tract

(2020) Qin Yan Gao et al.   Journal of Digestive Diseases

COVID-19 infection: the perspectives on immune responses

(2020) Yufang Shi et al.   CELL DEATH AND DIFFERENTIATION

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

(2020) Jia Liu et al.   Cell Discovery

Gut microbiome contributes to impairment of immunity in pulmonary tuberculosis patients by alteration of butyrate and propionate producers

(2017) Abhijit Maji et al.   ENVIRONMENTAL MICROBIOLOGY

Gut-Bioreactor and Human Health in Future

(2017) Hemant J. Purohit   INDIAN JOURNAL OF MICROBIOLOGY

Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity

(2016) Melanie Schirmer et al.   CELL

Composition of the gut microbiota modulates the severity of malaria

(2016) Nicolas F. Villarino et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Coming soon: probiotics-based malaria vaccines

(2015) Che Julius Ngwa et al.   TRENDS IN PARASITOLOGY

Antiviral activity of the Indian medicinal plant extract,Swertia chirataagainst herpes simplex viruses: A study byin-vitroand molecular approach

(2009) V Gopalkrishna et al.   Indian Journal of Medical Microbiology